Cyntellect Lands $1.3M Phase II SBIR Grant To Develop Cloning Apps for LEAP Platform | GenomeWeb
Cyntellect this week announced that it has received a $1.3 million Phase II SBIR grant from the National Institutes of Health to help it further develop assay and software applications for its Laser-Enabled Analysis and Processing technology. 
 
Cyntellect CBO James Linton declined to discuss specific plans for future LEAP applications, but said that the company would seek feedback from customers and others in the field about how to best to exploit the technology’s ability to address unmet market needs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.